CN105434970A - 一种用于治疗高脂血症的药物 - Google Patents

一种用于治疗高脂血症的药物 Download PDF

Info

Publication number
CN105434970A
CN105434970A CN201610027206.2A CN201610027206A CN105434970A CN 105434970 A CN105434970 A CN 105434970A CN 201610027206 A CN201610027206 A CN 201610027206A CN 105434970 A CN105434970 A CN 105434970A
Authority
CN
China
Prior art keywords
parts
hyperlipemia
phlegm
fructus
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610027206.2A
Other languages
English (en)
Inventor
俞天阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610027206.2A priority Critical patent/CN105434970A/zh
Publication of CN105434970A publication Critical patent/CN105434970A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8884—Arisaema, e.g. Jack in the pulpit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888—Pinellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明涉及一种用于治疗高脂血症的药物，它是由以下重量配比的原料药材制备而成：天竺黄8份、莱菔子6份、法半夏6份、天南星6份、香橼6份、茯苓9份、莲子3份、红花8份、广枣2份、丹皮8份、天冬3份、荷叶6份。本发明运用：天竺黄清热豁痰；莱菔子降气化痰；法半夏、天南星燥湿消痰；香橼疏肝化痰；茯苓健脾利湿；莲子补脾益肾；红花活血散瘀；广枣行气活血；丹皮凉血活血；天冬养阴生津；荷叶升发清阳。诸药合用，共奏化痰祛瘀之效，达到治疗高脂血症的目的。临床实验证明，本发明能够安全有效治疗高脂血症。

Description

一种用于治疗高脂血症的药物
技术领域
本发明涉及一种中药，具体涉及一种用于治疗高脂血症的药物。
背景技术
高脂血症是指血脂水平过高，可直接引起一些严重危害人体健康的疾病，如动脉粥样硬化、冠心病、胰腺炎等。
高脂血症的临床表现主要是脂质在真皮内沉积所引起的黄色瘤和脂质在血管内皮沉积所引起的动脉硬化。尽管高脂血症可引起黄色瘤，但其发生率并不很高；而动脉粥样硬化的发生和发展又是一种缓慢渐进的过程。因此在通常情况下，多数患者并无明显症状和异常体征。不少人是由于其他原因进行血液生化检验时才发现有血浆脂蛋白水平升高。
关于高脂血症的诊断标准，目前国际和国内尚无统一的方法。既往认为血浆总胆固醇浓度>5.17mmol/L(200mg/dl)可定为高胆固醇血症，血浆三酰甘油浓度>2.3mmol/L(200mg/dl)为高三酰甘油血症。各地由于所测人群不同以及所采用的测试方法的差异等因素，所制定的高脂血症诊断标准不一。但为了防治动脉粥样硬化和冠心病，合适的血浆胆固醇水平应该根据患者未来发生心脑血管疾病的风险来决定，发生风险越高，合适的血浆胆固醇水平应该越低。
新的标准建议在LDL-C浓度>130mg/dl时开始药物治疗，以LDL-C浓度<100mg/dl为治疗目标，如果未来发生心脑血管疾病的风险很高应该更早的开始药物治疗和采取更严格的治疗目标。低HDL-C浓度为冠心病的一项危险因素，为<40mg/dl。降低了三酰甘油的分类的标准，更注重其中度升高。
药物治疗以降低血清总胆固醇和LDL胆固醇为主的有他汀类和树脂类。以降低血清三酰甘油为主的药物有贝特类和烟酸类。
本发明所涉及药材均可见记载于《中国药典》。
发明内容
本发明旨在提供一种用于治疗高脂血症的药物，通过选择合适的药材及其配比，达到安全有效治愈高脂血症的目的。
为了达到上述目的，本发明采用以下技术方案：
一种用于治疗高脂血症的药物，其特征在于，它是由以下重量配比的原料药材制备而成：天竺黄8份、莱菔子6份、法半夏6份、天南星6份、香橼6份、茯苓9份、莲子3份、红花8份、广枣2份、丹皮8份、天冬3份、荷叶6份。
下面结合中药学理论说明本发明有益效果：
发明人认为，高脂血症属于中医学“痰湿”、“血瘀”的范畴。由于患者过食肥甘厚味、饮食不节及情志内伤等，致水谷精微不化而变生痰浊。另外，痰湿困脾，致气血化生乏源，代谢发生障碍；子病及母，脾土虚则心火虚，气血津液运行不畅，痰瘀阻塞脉道，脂凝血脉而发生高脂血症。如《医宗必读》语：“脾土虚弱，清者难升，浊者难降，留中滞膈，瘀而成痰。”因此，痰瘀是引起高脂血症的重要病理因素，痰湿瘀阻证是本病辨证之本，治宜化痰祛瘀。
本发明运用：天竺黄清热豁痰；莱菔子降气化痰；法半夏、天南星燥湿消痰；香橼疏肝化痰；茯苓健脾利湿；莲子补脾益肾；红花活血散瘀；广枣行气活血；丹皮凉血活血；天冬养阴生津；荷叶升发清阳。诸药合用，共奏化痰祛瘀之效，达到治疗高脂血症的目的。
下面结合临床实验数据说明本发明的有益效果：
1、一般资料
1.1纳入标准
①年龄40～65岁；②符合《中国成人血脂异常防治指南》高脂血症诊断标准；③能够配合治疗、维持低脂饮食者；④患者知情同意。
1.2排除标准
①4周内使用过西药降脂治疗者；②妊娠、哺乳期妇女及本研究药品过敏者；③合并严重的多器官多系统性疾病者；④由药物所致高脂血症者；⑤正在使用肝素、甲状腺素药物治疗影响脂代谢所致继发性高脂血症的患者；⑥CK(肌酸激酶)水平大于正常值上限的3倍以上，并对HMG—CoA还原酶过敏者；⑦合并其他内分泌疾病或肝、肾、造血系统等严重原发性疾病、精神病及恶性肿瘤者。
1.3一般资料
发明人2013年10月到2014年10月间共收集60例高脂血症患者。随机分为：治疗组30例，对照组30例。其中治疗组男20例、女10例，年龄45～61岁，病程7个月～2.5年；对照组男18例、女12例，年龄43～60岁间，病程6个月～3年。两组性别、年龄、病程等资料无显著性差异，具有可比性。
2、治疗方法
治疗组口服本发明按照具体实施例3制得的胶囊，每日3次。治疗1个月。
对照组口服非诺贝特胶囊(浙江国镜药业有限公司，每粒0.2g)，0.2g每天。治疗1个月。
3、疗效标准与治疗结果
3.1观察指标
①血脂6项：观察两组患者血清中总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL—C)、低密度脂蛋白胆固醇(LDL—C)，载脂蛋白A(ApoA)及载脂蛋～B(ApoB)。②血液流变学指标：高切变率全血粘度、低切变率全血粘度、血浆粘度、红细胞压积、纤维蛋白原。
3.2疗效标准
临床控制：血脂恢复正常水平。显效：TC下降≥20％，TG下降≥40％，或HDL—C上升≥0.260mmol/L，满足以上任何1项即可。有效：10％≤TC下降<20％，20％≤TG下降<40％，0.104mmol/L≤HDL-C上升<0.260mmol/L，满足以上任何1项即可。无效：检测血脂未达到以上标准者。
3.3治疗统计结果见表1。
表1两组疗效比较
可见，本发明制得的药物能够安全有效治疗高脂血症，治愈率高。
具体实施方式
为了更好地理解和实施本发明，下面结合具体实施例进一步说明本发明。
实施例1
称取：天竺黄8克、莱菔子6克、法半夏6克、天南星6克、香橼6克、茯苓9克、莲子3克、红花8克、广枣2克、丹皮8克、天冬3克、荷叶6克；加8倍量水，煎煮1.5小时，过滤；滤渣加6倍量水，煎煮1小时，过滤；合并滤液，浓缩至120克，即得符合正常成人一天用量的煎剂。
用于治疗高脂血症。口服，每日服用一次。
实施例2
称取：天竺黄8克、莱菔子6克、法半夏6克、天南星6克、香橼6克、茯苓9克、莲子3克、红花8克、广枣2克、丹皮8克、天冬3克、荷叶6克；加10倍量水，煎煮2小时，过滤；滤渣加8倍量水，煎煮1.5小时，过滤；合并滤液，浓缩，干燥，包装，即得符合正常成人一天用量的散剂。
用于治疗高脂血症。口服，每日分早晚两次服用。
实施例3
称取：天竺黄8克、莱菔子6克、法半夏6克、天南星6克、香橼6克、茯苓9克、莲子3克、红花8克、广枣2克、丹皮8克、天冬3克、荷叶6克；加6倍量水，煎煮3次，每次煎煮1小时，合并煎煮液，浓缩，干燥，装入胶囊壳，即得符合正常成人一天用量的胶囊剂。
用于治疗高脂血症。口服，每日分早中晚三次服用。

Claims (4)

1.一种用于治疗高脂血症的药物，其特征在于，它是由以下重量配比的原料药材制备而成：天竺黄8份、莱菔子6份、法半夏6份、天南星6份、香橼6份、茯苓9份、莲子3份、红花8份、广枣2份、丹皮8份、天冬3份、荷叶6份。
2.如权利要求1所述的一种用于治疗高脂血症的药物，其特征在于，其制备方法为：称取：天竺黄8份、莱菔子6份、法半夏6份、天南星6份、香橼6份、茯苓9份、莲子3份、红花8份、广枣2份、丹皮8份、天冬3份、荷叶6份；加8倍量水，煎煮1.5小时，过滤；滤渣加6倍量水，煎煮1小时，过滤；合并滤液，浓缩至120份，即得煎剂；上述份均是指重量份。
3.如权利要求1所述的一种用于治疗高脂血症的药物，其特征在于，其制备方法为：称取：天竺黄8份、莱菔子6份、法半夏6份、天南星6份、香橼6份、茯苓9份、莲子3份、红花8份、广枣2份、丹皮8份、天冬3份、荷叶6份；加10倍量水，煎煮2小时，过滤；滤渣加8倍量水，煎煮1.5小时，过滤；合并滤液，浓缩，干燥，包装，即得散剂；上述份均是指重量份。
4.如权利要求1所述的一种用于治疗高脂血症的药物，其特征在于，其制备方法为：称取：天竺黄8份、莱菔子6份、法半夏6份、天南星6份、香橼6份、茯苓9份、莲子3份、红花8份、广枣2份、丹皮8份、天冬3份、荷叶6份；加6倍量水，煎煮3次，每次煎煮1小时，合并煎煮液，浓缩，干燥，装入胶囊壳，即得胶囊剂；上述份均是指重量份。
CN201610027206.2A 2016-01-15 2016-01-15 一种用于治疗高脂血症的药物 Pending CN105434970A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610027206.2A CN105434970A (zh) 2016-01-15 2016-01-15 一种用于治疗高脂血症的药物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610027206.2A CN105434970A (zh) 2016-01-15 2016-01-15 一种用于治疗高脂血症的药物

Publications (1)

Publication Number Publication Date
CN105434970A true CN105434970A (zh) 2016-03-30

Family

ID=55545895

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610027206.2A Pending CN105434970A (zh) 2016-01-15 2016-01-15 一种用于治疗高脂血症的药物

Country Status (1)

Country Link
CN (1) CN105434970A (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101214352A (zh) * 2007-01-05 2008-07-09 闫淑丽 一种治疗高脂血症的中药
CN102343053A (zh) * 2011-10-19 2012-02-08 成都绿迪科技有限公司 一种治疗高脂血症的中药

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101214352A (zh) * 2007-01-05 2008-07-09 闫淑丽 一种治疗高脂血症的中药
CN102343053A (zh) * 2011-10-19 2012-02-08 成都绿迪科技有限公司 一种治疗高脂血症的中药

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
林丽娥等: "降脂苓丹汤治疗高脂血症36例的临床疗效", 《中国实用医药》 *

Similar Documents

Publication Publication Date Title
CN1558768A (zh) 一种中药组合物及其制备方法
CN108853433A (zh) 一种治疗糖尿病肾病的中药及其制备方法
CN105381132A (zh) 一种用于治疗甲状腺结节的药物
CN104857436B (zh) 具有抗肝癌活性的中药复方组合物及其制备方法和应用
CN103550688B (zh) 一种治疗心悸的中药组合物
CN105079532A (zh) 一种具有降血脂、减肥功效的保健绿茶及其制作方法
CN104435690B (zh) 一种健脾益肾中药组合物及其制备方法
CN102309705B (zh) 一种降低血尿酸的药物及其制备方法和用途
CN107854656A (zh) 一种降脂中药组合物及其制备方法和用途
CN101829237B (zh) 用于治疗痰浊瘀阻证引起的高血脂症药物及其制备工艺
CN105434970A (zh) 一种用于治疗高脂血症的药物
CN110251568A (zh) 一种治疗白癜风的中药复方及其制备方法
CN108743885A (zh) 一种治疗糖尿病大血管病变的中药及其制备方法
CN103007002B (zh) 一种治疗高脂血症的中药降脂汤
CN104127545B (zh) 四数九里香及其提取物在制备药物中的应用
CN102836315A (zh) 一种预防调理转归肿瘤的中药组合物及其制备方法
CN107137542A (zh) 一种降血脂的药物组合物
CN1317003C (zh) 治疗高脂血症胶囊及其制备工艺
CN105853582A (zh) 一种含有艾叶的治疗胆石症的药物制剂及其制备方法
CN106039110A (zh) 一种女性减肥组合物及其制备方法
CN107233540A (zh) 一种治疗类风湿关节炎的中药组合物
CN105168488A (zh) 一种治疗高血脂症的中药组合物
Xiaohan et al. A Preliminary Study on Fan Xiufeng's Clinical Experience in Treating Chest Arthralgia and Heart Pain with Yang Deficiency and Phlegm and Blood Stasis
CN105169187A (zh) 一种组合物及其应用，其制备方法以及含有该组合物的药物、食品
CN103735951B (zh) 一种治疗银屑病的汤剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160330